Healthcare -
Biotechnology - NASDAQ - US
$ 0.3874
-1.95 %
$ 66.1 M
Market Cap
-4.84
P/E
XFOR - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities XFOR - X4 Pharmaceuticals, Inc.
88.5 M
LAST VALUE
9.19%
2 YEAR CAGR
84.77%
5 YEAR CAGR
0.00%
10 YEAR CAGR